![Amy Mahery](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 6 $ al 31/08/2026
Amy Mahery is currently an Independent Director at CNS Pharmaceuticals, Inc. since 2024.
Formerly, Ms. Mahery was Chief Commercial Officer at Roivant Sciences Ltd. from 2022 to 2024 and Senior Vice President at EMD Serono, Inc. from 2021 to 2022.
Ms. Mahery completed undergraduate education at Trinity College.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/08/2026 | 1 ( 0 % ) | 6 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 18/01/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 01/12/2024 |
EMD Serono, Inc.
 EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Corporate Officer/Principal | 01/07/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Roivant Sciences Ltd.
 Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Health Technology |
Trinity College
 Trinity College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CNS Pharmaceuticals, Inc.
 CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
